49 related articles for article (PubMed ID: 3075463)
1. Synovial localization of tumor necrosis factor in patients with rheumatoid arthritis.
Husby G; Williams RC
J Autoimmun; 1988 Aug; 1(4):363-71. PubMed ID: 3075463
[TBL] [Abstract][Full Text] [Related]
2. Thrombospondin 2 Promotes IL-6 Production in Osteoarthritis Synovial Fibroblasts via the PI3K/AKT/NF-κB Pathway.
Hou CH; Tang CH; Chen PC; Liu JF
J Inflamm Res; 2021; 14():5955-5967. PubMed ID: 34803392
[TBL] [Abstract][Full Text] [Related]
3. Salivary interleukin 6, interleukin 8, interleukin 17A, and tumour necrosis factor α levels in patients with periodontitis and rheumatoid arthritis.
Kaczyński T; Wroński J; Głuszko P; Kryczka T; Miskiewicz A; Górski B; Radkowski M; Strzemecki D; Grieb P; Górska R
Cent Eur J Immunol; 2019; 44(3):269-276. PubMed ID: 31933536
[TBL] [Abstract][Full Text] [Related]
4. Risk of tuberculosis during infliximab therapy for inflammatory bowel disease, rheumatoid arthritis, and spondyloarthropathy: A meta-analysis.
Wang Q; Wen Z; Cao Q
Exp Ther Med; 2016 Sep; 12(3):1693-1704. PubMed ID: 27588089
[TBL] [Abstract][Full Text] [Related]
5. Rheumatoid arthritis bone fragility is associated with upregulation of IL17 and DKK1 gene expression.
Caetano-Lopes J; Rodrigues A; Lopes A; Vale AC; Pitts-Kiefer MA; Vidal B; Perpétuo IP; Monteiro J; Konttinen YT; Vaz MF; Nazarian A; Canhão H; Fonseca JE
Clin Rev Allergy Immunol; 2014 Aug; 47(1):38-45. PubMed ID: 23546988
[TBL] [Abstract][Full Text] [Related]
6. TNFSF15 Modulates Neovascularization and Inflammation.
Zhang Z; Li LY
Cancer Microenviron; 2012 Dec; 5(3):237-47. PubMed ID: 22833050
[TBL] [Abstract][Full Text] [Related]
7. Carrageenan-induced acute inflammation in the mouse air pouch synovial model. Role of tumour necrosis factor.
Romano M; Faggioni R; Sironi M; Sacco S; Echtenacher B; Di Santo E; Salmona M; Ghezzi P
Mediators Inflamm; 1997; 6(1):32-8. PubMed ID: 18472831
[TBL] [Abstract][Full Text] [Related]
8. Molecular interactions between T cells and fibroblast-like synoviocytes: role of membrane tumor necrosis factor-alpha on cytokine-activated T cells.
Tran CN; Lundy SK; White PT; Endres JL; Motyl CD; Gupta R; Wilke CM; Shelden EA; Chung KC; Urquhart AG; Fox DA
Am J Pathol; 2007 Nov; 171(5):1588-98. PubMed ID: 17823284
[TBL] [Abstract][Full Text] [Related]
9. Elevated angiogenin levels in synovial fluid from patients with inflammatory arthritis and secretion of angiogenin by cultured synovial fibroblasts.
Lioté F; Champy R; Moenner M; Boval-Boizard B; Badet J
Clin Exp Immunol; 2003 Apr; 132(1):163-8. PubMed ID: 12653852
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumour necrosis factor therapy for severe inflammatory arthritis: two years of experience in Northern Ireland.
Cairns AP; Taggart AJ
Ulster Med J; 2002 Nov; 71(2):101-5. PubMed ID: 12513005
[TBL] [Abstract][Full Text] [Related]
11. Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.
Culy CR; Keating GM
Drugs; 2002; 62(17):2493-537. PubMed ID: 12421111
[TBL] [Abstract][Full Text] [Related]
12. Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors.
Mease PJ
Ann Rheum Dis; 2002 Apr; 61(4):298-304. PubMed ID: 11874829
[TBL] [Abstract][Full Text] [Related]
13. Etanercept: therapeutic use in patients with rheumatoid arthritis.
Garrison L; McDonnell ND
Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I65-9. PubMed ID: 10577976
[TBL] [Abstract][Full Text] [Related]
14. Etanercept: a review of its use in rheumatoid arthritis.
Jarvis B; Faulds D
Drugs; 1999 Jun; 57(6):945-66. PubMed ID: 10400407
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effects of systemic anti-tumour necrosis factor alpha treatment in human/murine SCID arthritis.
Schädlich H; Ermann J; Biskop M; Falk W; Sperling F; Jüngel A; Lehmann J; Emmrich F; Sack U
Ann Rheum Dis; 1999 Jul; 58(7):428-34. PubMed ID: 10381487
[TBL] [Abstract][Full Text] [Related]
16. The future role of anti-tumour necrosis factor (TNF) products in the treatment of rheumatoid arthritis.
Camussi G; Lupia E
Drugs; 1998 May; 55(5):613-20. PubMed ID: 9585859
[TBL] [Abstract][Full Text] [Related]
17. Cytokine and nitric oxide production in the acute phase of bacterial cell wall-induced arthritis.
Fuseler JW; Conner EM; Davis JM; Wolf RE; Grisham MB
Inflammation; 1997 Feb; 21(1):113-31. PubMed ID: 9179627
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor priming of peripheral blood neutrophils from rheumatoid arthritis patients.
Kowanko IC; Ferrante A; Clemente G; Youssef PP; Smith M
J Clin Immunol; 1996 Jul; 16(4):216-21. PubMed ID: 8840223
[TBL] [Abstract][Full Text] [Related]
19. Detection of tumour necrosis factor alpha and interleukin-1 beta in the rheumatoid osteoarthritic cartilage-pannus junction by immunohistochemical methods.
Miller VE; Rogers K; Muirden KD
Rheumatol Int; 1993; 13(2):77-82. PubMed ID: 8356394
[TBL] [Abstract][Full Text] [Related]
20. IL-2 enhances polyclonal IgM but not IgM-rheumatoid factor synthesis by activated human peripheral blood B cells.
Callaghan M; Whelan A; Feighery C; Bresnihan B
Clin Exp Immunol; 1993 Aug; 93(2):212-7. PubMed ID: 8348746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
